Cargando…
Patient-derived organoids potentiate precision medicine in advanced clear cell renal cell carcinoma
To investigate the role of patient-derived organoid (PDO) model in the precision medicine of advanced clear cell renal cell carcinoma (ccRCC), we retrospectively analyzed the clinical data of seven cases of ccRCC diagnosed by operation and pathology in Renji Hospital from September 2021 to September...
Autores principales: | Xue, Yizheng, Wang, Bingran, Tao, Yiying, Xia, Jun, Yuan, Kedi, Zheng, Junhua, Zhai, Wei, Xue, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762875/ https://www.ncbi.nlm.nih.gov/pubmed/36544542 http://dx.doi.org/10.1093/pcmedi/pbac028 |
Ejemplares similares
-
Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma
por: Wang, Bingran, et al.
Publicado: (2022) -
Serum extracellular vesicles derived hsa-miR-320d as an indicator for progression of clear cell renal cell carcinoma
por: Xue, Yizheng, et al.
Publicado: (2023) -
Patient-derived models facilitate precision medicine in liver cancer by remodeling cell-matrix interaction
por: Chen, Kaiwen, et al.
Publicado: (2023) -
Characteristics of Gut Microbiota in Patients With Clear Cell Renal Cell Carcinoma
por: Chen, Yang, et al.
Publicado: (2022) -
Advanced Xenograft Model with Cotransplantation of Patient-Derived Organoids and Endothelial Colony-Forming Cells for Precision Medicine
por: Kwon, Junhye, et al.
Publicado: (2021)